Erika Hamilton: Happy to share the publication in Annals of Oncology

Erika Hamilton shared a post on X:

“Happy to share the publication in Annals of Oncology of the novel oral SERD, camizestrant, in patients with HR+ metastatic breast cancer.

Very excited for these novel endocrine backbones to get in the clinic!

Clinical trials advance care!”

Additional information.
Source: Erika Hamilton/X

Erika Hamilton is a medical oncologist and the Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute (USA). In her role, Dr. Hamilton oversees the research program and clinical trial menu for gynecologic and breast cancer from a medical oncology perspective.

Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference, and a board member of the Susan G. Komen Foundation of Central Tennessee.